Genome Medical Funding: $60M Raised, Series B (2020)
Genome Medical is based in San Francisco, California. It has raised $60M in total funding. Latest round: Series B.
Genome Medical funding overview
Genome Medical is based in San Francisco, California. Genome Medical has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Genome Medical runs through 2020; nothing later has been disclosed. Investors on record include Canaan Partners, Illumina Ventures, HealthInvest Equity Partners, Flywheel Ventures, GE Ventures, Perceptive Advisors and 5 others. 11 distinct backers are named across the disclosed rounds.
Genome Medical at a glance
Total raised
$60M
Latest round
Series B
Latest round date
June 2020
Headquarters
San Francisco, California
Notable investors
Canaan Partners, Illumina Ventures, HealthInvest Equity Partners, Flywheel Ventures, GE Ventures, Perceptive Advisors, Kaiser Permanente Ventures, Techammer
Frequently asked about Genome Medical funding
How much has Genome Medical raised?
Genome Medical has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Genome Medical?
Canaan Partners, Illumina Ventures, HealthInvest Equity Partners, Flywheel Ventures, GE Ventures, Perceptive Advisors are named among the investors backing Genome Medical.
What was the latest Genome Medical funding round?
The most recent disclosed round is a Series B, announced in June 2020.
Where is Genome Medical based?
Genome Medical is based in San Francisco, California.
When did Genome Medical last raise?
The last disclosed Genome Medical round closed in June 2020 at Series B.
We update the Genome Medical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Francisco and their backers are listed below.
